Gainers
- PLx Pharma (NASDAQ:PLXP) stock increased by 10.6% to $0.23 during Wednesday's after-market session. The market value of their outstanding shares is at $6.5 million.
- Clovis Oncology (NASDAQ:CLVS) shares rose 9.76% to $0.12. Trading volume for this security closed at 5.4 million, accounting for 125.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.7 million.
- OpGen (NASDAQ:OPGN) stock increased by 9.09% to $0.18. Today's trading volume for this security ended up closing at 2.9 million shares, which is 72.0 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $9.6 million.
- Champions Oncology (NASDAQ:CSBR) shares rose 8.26% to $4.98. The market value of their outstanding shares is at $67.3 million. The company's, Q2 earnings came out yesterday.
- Humanigen (NASDAQ:HGEN) stock moved upwards by 8.18% to $0.14. At the close, Humanigen's trading volume reached 120.5K shares. This is 3.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $16.3 million.
- Owlet (NYSE:OWLT) shares rose 6.78% to $0.71. The market value of their outstanding shares is at $81.5 million.
Losers
- Novavax (NASDAQ:NVAX) shares fell 13.3% to $14.94 during Wednesday's after-market session. This security traded at a volume of 598.6K shares come close, making up 11.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $1.1 billion.
- Intelligent Bio Solutions (NASDAQ:INBS) shares decreased by 8.5% to $0.32. The market value of their outstanding shares is at $5.8 million.
- Vallon Pharmaceuticals (NASDAQ:VLON) shares declined by 6.8% to $0.48. Vallon Pharmaceuticals's trading volume hit 21.2 million shares by close, accounting for 4115.0% of its average volume over the last 100 days. The market value of their outstanding shares is at $6.1 million.
- TransCode Therapeutics (NASDAQ:RNAZ) stock declined by 5.85% to $0.43. The company's market cap stands at $5.5 million.
- ImmuCell (NASDAQ:ICCC) stock fell 5.01% to $6.26. The company's market cap stands at $48.4 million.
- Vincerx Pharma (NASDAQ:VINC) stock declined by 5.0% to $0.83. Trading volume for this security closed at 541.7K, accounting for 274.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $17.5 million. See Also:
This article was generated by Benzinga's automated content engine and reviewed by an editor.
勝者だ
- PLX製薬会社ナスダック(Sequoia Capital:PLXP)株価は水曜日盤後に10.6%上昇し、0.23ドルに上昇した。彼らの流通株の時価は650万ドルだ
- クロビス腫瘍学ナスダック(Sequoia Capital:CLVS)株価は9.76%から0.12ドル上昇した。この証券の出来高は540万であり,過去100日の終日平均出来高の125.9を占めている。彼らの流通株の時価は1,670万ドルだ
- OpGenナスダック株式コード:OPGNは9.09%上昇し、0.18ドルに上昇した。この証券の今日の出来高は290万株で、過去100日間の平均出来高の72.0%だった。彼らの流通株の時価は960万ドルだ
- チャンピオン腫瘍学ナスダック(Sequoia Capital:CSBR)株価は8.26%上昇し、4.98ドルに上昇した。彼らの流通株の時価は6730万ドルだ。昨日、同社の第2四半期の収益が発表された
- 人文精神ナスダック株コード:HGENは8.18%上昇し、0.14ドルに上昇した。終値時,Humanigenの出来高は120.5 K株に達した。これは過去100日間の平均出来高の3.2%である。彼らの流通株の時価は1,630万ドルだ
- フクロウ.フクロウ(ニューヨーク証券取引所コード:OWLT)株価は6.78%上昇し、0.71ドルに上昇した。彼らの流通株の時価は8150万ドルだ
敗者は
- ノワールナスダック株価は水曜日盤後に13.3%下落し、14.94ドルになった。この証券の出来高は598.6 K株で、598.6 K株に近く、過去100日間の平均出来高の11.8%を占めている。彼らの流通株の時価は11億ドルだ
- 知的バイオソリューションナスダック株コード:INBS)株価は8.5%下落し、0.32ドルに下落した。彼らの流通株の時価は580万ドルだ
- バロン製薬会社ナスダック(Tmall:VLON)株価は6.8%下落し、0.48ドルになった。終値までのワロン製薬の出来高は2,120万株に達し,過去100日の平均出来高の4115.0%を占めた。彼らの流通株の時価は610万ドルだ
- コード変換治療会社ナスダック株価は5.85%下落し、0.43ドルに下落した。同社の時価は550万ドルである
- 免疫細胞ナスダック(ICCC:ICCC)株価は5.01%下落し、6.26ドルになった。同社の時価は4840万ドル
- Vincerx製薬会社ナスダック(Tmall:VUC)株価は5.0%下落し、0.83ドルになった。この証券の出来高は541.7 Kであり,過去100日の終日平均出来高の274.8を占めている。彼らの流通株の時価は1,750万ドルだまた会いましょう
本稿では,Benzingaの自動コンテンツエンジンから生成され,編集査読される.